Genovefa A. Papanicolaou

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

Dimitrios P. Kontoyiannis, Kieren A. Marr, Benjamin J. Park et al. · Clinical Infectious Diseases · 2010 · 1.4K citations

Determinants of COVID-19 disease severity in patients with cancer

Elizabeth Robilotti, N. Esther Babady, Peter A. Mead et al. · Nature Medicine · 2020 · 623 citations · Full text

Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility

Louis B. Rice, Sandra Willey, Genovefa A. Papanicolaou et al. · Antimicrobial Agents and Chemotherapy · 1990 · 382 citations · Full text

Ceftazidime Resistance, Klebsiella Pneumoniae, Antibiotic Resistance +16

CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation

Francisco M. Marty, Drew J. Winston, Scott D. Rowley et al. · New England Journal of Medicine · 2013 · 370 citations · Full text

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Francisco M. Marty, Per Ljungman, Genovefa A. Papanicolaou et al. · The Lancet Infectious Diseases · 2011 · 345 citations

Transplantation, Treatment And Prevention, Randomised Trial +9